<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ911106-0062</DOCNO><DOCID>911106-0062.</DOCID><HL>   OTC Focus:   Stocks Finish Mixed After Two Days   Of Decline, but Rebound Is Unconvincing   ----   By Dave Pettit   Staff Reporter of The Wall Street Journal</HL><DATE>11/06/91</DATE><SO>WALL STREET JOURNAL (J), PAGE C6</SO><IN>STOCK INDEXES (NDX)OTC GENERAL MARKET COMMENT (OTC)STOCK MARKET, OFFERINGS (STK)U.S. STOCK MARKET STATISTICS (STT)</IN><NS>STOCK AND OTHER INDEXES (NDX)STOCK andamp; OTHER MARKET NEWS (STK)</NS><RE>NORTH AMERICA (NME)UNITED STATES (US)</RE><LP>   NEW YORK -- Over-the-counter stocks closed mixed, stagingan unconvincing recovery from their recent weakness.   After two consecutive losing sessions, the NasdaqComposite Index advanced 1.32, or 0.25%, yesterday to 538.82.Declining issues, though, outpaced advancers, 1,007 to 980.</LP><TEXT>   The Nasdaq index ended below its early high of 540.41, butit managed to avoid the losses posted by Big Board indexes.The New York Stock Exchange Composite Index fell 0.75, or0.35%, while the Dow Jones Industrial Average lost 14.31, or0.47%.   National Market System volume rose to 139,400,000 sharesfrom 123,410,000 Monday. Activity, though, was well below thepace recorded last week, when the market twice establishedrecord highs.   Market observers attributed the Nasdaq market's tepidrecovery yesterday to worries about the sluggish recovery inthe U.S. economy and to the lack of a Federal Reserve Boardmove to cut interest rates. Many investors still anticipate amove by the Fed this week.   The Nasdaq index was buoyed by gains in several of themarket's largest issues.   Microsoft rose 2 3/4 to 93 3/4, and Intel jumped 1 to 42,together adding 0.78 to the Nasdaq composite.   Jack Muldowney, head of equity trading at Scott andamp;Stringfellow Financial, attributed the market's inability tomaintain its early gains to increased concern among investors&quot;that the market is getting a little bit pricey.&quot;   After stocks advanced recently because of the currentlow-interest-rate environment, Mr. Muldowney said, &quot;Maybe{the market} is just running out of gas and it's time for itto have a correction.&quot; Low yields on other investments overthe past several months have helped prompt investors todirect additional money into stocks.   Don Hays, director of investment strategy at WheatFirst-Butcher andamp; Singer, said he expects the OTC market totrade in a pattern of &quot;three steps up, two steps back&quot; untilthe middle of next month. By then, he said, investors willbegin to see indications that earnings are improving and thatconsumer confidence is rising.   Mr. Hays said he expects fourth-quarter earnings to bewell above year-earlier levels, in part because earnings werelow in the 1990 fourth quarter. Meanwhile, he said, consumerswith home equity loans outstanding will get a psychologicalboost this month when their monthly payments are reducedbecause of the mid-September prime rate cuts at many banks.   Geraghty andamp; Miller slumped 4 1/8 to 13 3/8. The Plainview,N.Y., concern reported third-quarter net income of 20 cents ashare, above the 16 cents a share it earned last year butbelow the 23-cents-a-share mean estimate of analysts surveyedby First Call, a unit of Thomson Financial Networks. Thecompany projected that its 1991 net will be at the low end ofanalysts' forecasts, which range from 75 to 85 cents a share.In 1990, it earned 60 cents a share.   Oxford Health Plans dropped 4 1/2 to 18 1/2 afterMontgomery Securities analyst Leonard Yaffe trimmed hisfiscal 1992 earnings estimate on the company to a range of 90to 95 cents a share from $1.20. The analyst citedexpectations of higher selling and administrative expenses atthe health maintenance organization operator.   Trans World Music slipped 3 to 18 1/2. PaineWebber analystCraig Bibb cut his rating on the stock to &quot;unattractive&quot; andslashed his estimate of its third-quarter net to two cents ashare from 10 cents a share, Dow Jones Professional InvestorReport said. The Albany, N.Y., retailer of music and videoproducts earned 11 cents a share a year earlier.   Software Toolworks rose 1/2 to 5 1/4 after the companyposted net of $1.2 million, or five cents a share, for itssecond quarter, ended Sept. 30, reversing a year-ago loss of$7 million, or 31 cents a share. Latest-quarter figuresinclude a charge of $600,000 for legal expenses.   Platinum Technology closed with a gain of 1/4 to 18 1/2 onvolume of 1.2 million shares after trading as high as 19 1/4.An issue of 4.3 million additional shares of its common wasoffered at $18 a share.   Immunex jumped 1 1/4 to 47 1/4. The Seattle biotechnologycompany announced that it began Phase I clinical trials ofInterleukin-1 receptor, a genetically engineered product thatwill initially be tested in treating allergies. Later, anImmunex spokesman said, the company hopes to test the productin patients suffering from rheumatoid arthritis andinflammatory bowel disease, among other problems.   Parlex closed with a gain of 1/4 at 3 after trading as lowas 2. An institutional investor sold a 5.7% stake in theMethuen, Mass., maker of semiconductor parts. A spokeswomansaid the shares were bought by another institution, but shewouldn't identify either of the parties.   State Auto Financial lost 7/8 to 15 3/8 after the companyreported third-quarter net of $2.4 million, or 41 cents ashare, down from $3 million, or 74 cents a share, a yearearlier. Its investment gain for the quarter totaled $92,000,compared with $816,000.   Isis Pharmaceuticals slipped 1 1/4 to 20 after the companyreported a third-quarter loss of 23 cents a share, wider thanits year-earlier loss of 17 cents a share. Separately, itfiled with the Securities and Exchange Commission for anoffering of two million common shares.   Applied Immune Sciences jumped 5 1/4 to 25 3/4. Companyofficials presented to a conference yesterday preliminarydata on a treatment Applied Immune is developing to helpacquired immune deficiency syndrome patients fight offopportunistic infections.   50-Off Stores jumped 1 3/4 to 20. After the market closedMonday, it reported that its comparable-store sales rose 4.9%in October. The stock fell 1 1/2 Monday, in part on worriesthat October sales would be disappointing.</TEXT></DOC>